CN1158389C - 一种用于鉴别有血管及癌症疾病患病风险的个体的方法 - Google Patents

一种用于鉴别有血管及癌症疾病患病风险的个体的方法 Download PDF

Info

Publication number
CN1158389C
CN1158389C CNB008122261A CN00812226A CN1158389C CN 1158389 C CN1158389 C CN 1158389C CN B008122261 A CNB008122261 A CN B008122261A CN 00812226 A CN00812226 A CN 00812226A CN 1158389 C CN1158389 C CN 1158389C
Authority
CN
China
Prior art keywords
concentration
serum
homocysteine
analyte
pepsin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB008122261A
Other languages
English (en)
Chinese (zh)
Other versions
CN1371427A (zh
Inventor
��١�����������
彭蒂·西波南
马蒂·哈科南
奥斯莫·斯沃瓦尼米
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biohit Oy
Original Assignee
Biohit Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biohit Oy filed Critical Biohit Oy
Publication of CN1371427A publication Critical patent/CN1371427A/zh
Application granted granted Critical
Publication of CN1158389C publication Critical patent/CN1158389C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806—Determination of free amino acids
    • G01N33/6812—Assays for specific amino acids
    • G01N33/6815—Assays for specific amino acids containing sulfur, e.g. cysteine, cystine, methionine, homocysteine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CNB008122261A 1999-08-31 2000-08-30 一种用于鉴别有血管及癌症疾病患病风险的个体的方法 Expired - Lifetime CN1158389C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI991836A FI107808B (fi) 1999-08-31 1999-08-31 Menetelmä verisuoni- sekä syöpäsairaudelle riskialttiin yksilön identifioimiseksi
FI19991836 1999-08-31

Publications (2)

Publication Number Publication Date
CN1371427A CN1371427A (zh) 2002-09-25
CN1158389C true CN1158389C (zh) 2004-07-21

Family

ID=8555217

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB008122261A Expired - Lifetime CN1158389C (zh) 1999-08-31 2000-08-30 一种用于鉴别有血管及癌症疾病患病风险的个体的方法

Country Status (7)

Country Link
EP (1) EP1210452A1 (https=)
JP (1) JP2003508059A (https=)
CN (1) CN1158389C (https=)
AU (1) AU6845600A (https=)
FI (1) FI107808B (https=)
RU (1) RU2247389C2 (https=)
WO (1) WO2001016356A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2312356C2 (ru) * 2005-12-28 2007-12-10 Федеральное государственное лечебно-профилактическое учреждение "Научно-клинический центр охраны здоровья шахтеров" Федерального агентства по энергетике РФ Способ оценки степени тяжести ишемического инсульта у лиц в возрасте до 50 лет
RU2413940C2 (ru) * 2009-02-02 2011-03-10 Государственное образовательное учреждение высшего профессионального образования Воронежская государственная технологическая академия Способ определения витамина b12 в водных растворах
RU2453001C1 (ru) * 2010-10-18 2012-06-10 Государственное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" Способ коррекции гипергомоцистеин индуцированного дефицита оксида азота l-норвалином в эксперименте
CN114924016B (zh) * 2022-04-28 2024-03-08 中国医学科学院北京协和医院 同时检测硫酸化及未硫酸化胃泌素g17的方法及其检测试剂盒

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI97304C (fi) * 1994-11-16 1996-11-25 Locus Genex Oy Menetelmä mahasyövän riskin seulonnaksi

Also Published As

Publication number Publication date
RU2247389C2 (ru) 2005-02-27
AU6845600A (en) 2001-03-26
WO2001016356A1 (en) 2001-03-08
CN1371427A (zh) 2002-09-25
JP2003508059A (ja) 2003-03-04
EP1210452A1 (en) 2002-06-05
FI107808B (fi) 2001-10-15
FI19991836L (fi) 2001-02-28

Similar Documents

Publication Publication Date Title
US10472400B2 (en) Cardiac troponin I ultra-sensitive detection reagent kit, and ultra-sensitive detection method therefor
JP3787121B2 (ja) ビタミンｄ代謝産物の検出方法
JP2002357608A (ja) 前進性グリコシル化終末産物を含有しない特異的結合アッセイの試薬および固相成分
CN1158389C (zh) 一种用于鉴别有血管及癌症疾病患病风险的个体的方法
Sheabar et al. Quantitative analysis of aflatoxin-albumin adducts
US20030124616A1 (en) Homocysteinylated transthyretin
CN106093430A (zh) 可用于检测糖尿病的标志物及其用途
CN102998462B (zh) Ⅲ型前胶原磁微粒化学发光免疫定量检测试剂盒及其制备方法
CN116298265A (zh) 一种应用了多级信号放大技术的hs-cTnT化学发光测定试剂盒
US4113433A (en) Radioimmunoassay of hormones and metabolites in blood serum and plasma
EP1076240B1 (en) Method for assaying crp with the use of phosphorylcholine
US10191069B2 (en) Accurate assay measurement of hydrophobic haptenic analytes
CN101606067A (zh) 测量血浆长正五聚蛋白ptx3水平的方法
EP4244243A1 (en) Polyol biomarkers for congenital disorders of glycosylation
RU2224258C2 (ru) Способ идентификации индивидуума, у которого существует риск необратимых неврологических повреждений, включающий в себя этапы количественного определения концентрации пепсиногена i (pgi) и витамина в12
JP2024516680A (ja) 敗血症の早期検出用のｉｌ６マーカーパネル
CN101324590A (zh) 一种测定雌三醇含量的免疫分析法
JP2003508059A5 (https=)
CN1589329A (zh) 总半胱氨酸测定
KR20220126900A (ko) 전신 홍반성 루푸스 진단용 바이오마커 조성물 및 이를 이용한 전신 홍반성 루푸스 진단에 필요한 정보를 제공하는 방법
CN104181309B (zh) 一种灵敏度高的肌钙蛋白i检测试剂盒
JPH0587809A (ja) 特定タンパク質の糖化割合の測定方法
Zappacosta et al. Analytical evaluation of a new immunonephelometric method for homocysteine measurement
SHINOGI et al. Measurement of metallothionein in rat tissues by a chromatographic method using the fluorometry of thiol groups
Sorensen et al. An enzyme antigen immunoassay for the determination of neuron-specific enolase in serum samples

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: BIOHIT BIOECH (HEFEI) CO., LTD.

Free format text: FORMER OWNER: BIOHIT OY

Effective date: 20141202

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; TO: 230000 HEFEI, ANHUI PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20141202

Address after: 230000 Anhui Province, Hefei high tech Zone Wangjiang Road, No. 800 Hefei Innovation Industrial Park D9 building a layer to five

Patentee after: Will Europe Han Biotechnology (Hefei) Co., Ltd.

Address before: Helsinki

Patentee before: Biohit OY

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20161228

Address after: Helsinki

Patentee after: Biohit OY

Address before: 230000 Anhui Province, Hefei high tech Zone Wangjiang Road, No. 800 Hefei Innovation Industrial Park D9 building a layer to five

Patentee before: Will Europe Han Biotechnology (Hefei) Co., Ltd.

EE01 Entry into force of recordation of patent licensing contract
EE01 Entry into force of recordation of patent licensing contract

Application publication date: 20020925

Assignee: Will Europe Han Biotechnology (Hefei) Co., Ltd.

Assignor: Biohit OY

Contract record no.: 2017990000359

Denomination of invention: Method for identifying individual at risk for vascular and cancer disease

Granted publication date: 20040721

License type: Exclusive License

Record date: 20170908

CX01 Expiry of patent term

Granted publication date: 20040721

CX01 Expiry of patent term